Work

NRG-CC008: A nonrandomized prospective clinical trial comparing the non-inferiority of salpingectomy to salpingo-oophorectomy to reduce the risk of ovarian cancer among BRCA1 carriers [SOROCk].

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps10615

Authors: Warner King Huh, Stephanie L. Pugh, Joan L. Walker, Kathryn Pennington, Elizabeth Lin Jewell, Laura J Havrilesky, Jeanne Carter, Carolyn Muller, Ronny Drapkin, Heather A. Lankes, Lyudmila Demora, Lisa A. Kachnic

Institutions: University of Alabama at Birmingham, UAB Medicine, NRG Oncology, University of Oklahoma Health Sciences Center, University of Washington, University of Washington Medical Center, Memorial Sloan Kettering Cancer Center, Duke Medical Center, Duke Cancer Institute, University of New Mexico, Dana-Farber Cancer Institute, Boston Medical Center

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4281695620

Cites:

Cited by: 15

Related to: 10